BioCentury
ARTICLE | Company News

Benu Biopharma Inc., Exponential Pharma Ventures LLC deal

May 10, 2010 7:00 AM UTC

Benu Biopharma and Exponential Pharma Ventures formed a new virtual company called LipimetiX LLC to develop apolipoprotein E (APOE) mimetics. The newco's lead compounds, AEM-18 and AEM-28, are in preclinical development to treat refractory hyperlipidemia due to genetic conditions and acute coronary syndrome (ACS). LipimetiX licensed AEM-28 and AEM-18, as well as additional ApoE mimetics and its Ligand Replacement Therapy (LRT) technology from the University of Alabama at Birmingham. ...